InterCure Stock: A Leader In Global Cannabis (NASDAQ:INCR)
The global cannabis market will eventually be bigger than North America, and InterCure is a leading company in global pharmaceutical cannabis. Click to read.
Stay updated with breaking news from Intercure Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global cannabis market will eventually be bigger than North America, and InterCure is a leading company in global pharmaceutical cannabis. Click to read.
InterCure Ltd (NASDAQ:NASDAQ:INCR) Q2 2022 Earnings Conference Call August 16, 2022, 08:30 ET Company Participants Adam Haliva - Communications Officer Alexander Rabinovitch - CEO &...
Record revenue ofover$37millioniin thesecondquarter of 2022
Record revenue of over $37 millioni in the second quarter of 2022 Representing an annual run rate of $150 million Adjusted EBITDAii for Q2 increased...
In this week’s edition - - DOJ to Address Cannabis “in the days ahead” - Germany Moves Towards Adult-Use Cannabis - Dentons’ Cannabis Group...